<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="publisher">pmed</journal-id><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="ppub">1549-1277</issn><issn pub-type="epub">1549-1676</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="doi">10.1371/journal.pmed.0020226</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Correspondence</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Non-Clinical Medicine/Health Policy</subject>
          <subject>Non-Clinical Medicine/Medical Education</subject>
        </subj-group>
        <subj-group subj-group-type="System Taxonomy">
          <subject>Editorial policies (including conflicts of interest)</subject>
          <subject>Health Policy</subject>
          <subject>Medical Education</subject>
          <subject>Medical journals</subject>
        </subj-group>
      </article-categories><title-group><article-title>Bold Suggestion by Smith</article-title><alt-title alt-title-type="running-head">Correspondence</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Cohen</surname>
            <given-names>David</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="n1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1"><label>1</label>
				
				<addr-line>Florida International University, Miami, Florida, United States of America</addr-line>
				
			</aff><author-notes>
        <corresp id="n1">E-mail: <email xlink:type="simple">david.cohen@fiu.edu</email></corresp>
      <fn fn-type="conflict" id="n2">
        <p> DC is a former editor of <italic>Ethical Human Sciences and Services</italic>, which published several articles critical of the drug industry, and has authored articles critical of drug industry sponsorship and influence on clinical psychopharmacology trials.</p>
      </fn></author-notes><pub-date pub-type="ppub">
        <month>7</month>
        <year>2005</year>
      </pub-date><pub-date pub-type="epub">
        <day>26</day>
        <month>7</month>
        <year>2005</year>
      </pub-date><volume>2</volume><issue>7</issue><elocation-id>e226</elocation-id><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2005</copyright-year><copyright-holder>David Cohen</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article page="e138" related-article-type="companion" vol="2" xlink:href="info:doi/10.1371/journal.pmed.0020138" xlink:title="essay" xlink:type="simple">
				<article-title>Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical</article-title>
			</related-article></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title/>
      <p>Richard Smith's key suggestion [<xref ref-type="bibr" rid="pmed-0020226-b1">1</xref>] is that medical journals “should stop publishing trials” and concentrate on “critically evaluating them.” This bold and radical suggestion deserves wide debate. It's obvious that many medical journals are losing relevance as vehicles for scientific information, but it's unclear what will save them. Even as journals strive to better enforce their conflicts-of-interest disclosure rules, drug companies will strive to find or create other publication outlets that can communicate to physicians precisely what advertisers wish to communicate. In sum, an unanticipated effect of purging clinical trial reports from medical journals might be an even larger proliferation of frank advertising outlets and messages that might more effectively catch doctors' attentions.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>Reference</title>
      <ref id="pmed-0020226-b1">
        <label>1</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Smith</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Medical journals are an extension of the marketing arm of pharmaceutical companies.</article-title>
          <source>PLoS Med</source>
          <year>2005</year>
          <volume>2</volume>
          <fpage>e138</fpage>
          <comment>doi: <ext-link ext-link-type="doi" xlink:href="http://dx.doi.org/10.1371/journal.pmed.0020138" xlink:type="simple">10.1371/journal.pmed.0020138</ext-link></comment>
        </nlm-citation>
      </ref>
    </ref-list>
    
  </back>
</article>